IRIS
SILINI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.367
EU - Europa 1.055
AS - Asia 786
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.354
CN - Cina 776
IE - Irlanda 341
UA - Ucraina 200
FI - Finlandia 159
DE - Germania 139
SE - Svezia 76
IT - Italia 52
GB - Regno Unito 45
FR - Francia 32
CA - Canada 13
VN - Vietnam 6
BE - Belgio 5
EU - Europa 3
AU - Australia 2
IN - India 2
NL - Olanda 2
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 3.214
Salva come PNG Salva come JPEG
Città #
Dublin 341
Chandler 335
Jacksonville 295
Nanjing 238
Ashburn 95
Nanchang 88
Beijing 83
Princeton 69
Hebei 68
Lawrence 63
Shenyang 60
Wilmington 59
Jiaxing 51
Changsha 46
Tianjin 45
Hangzhou 39
Medford 37
Boardman 33
Helsinki 28
Ann Arbor 23
Milan 23
Verona 17
Norwalk 15
Woodbridge 12
Toronto 11
Shanghai 9
Des Moines 8
Auburn Hills 7
Jinan 7
Kunming 7
Dearborn 6
Dong Ket 6
Brussels 5
Guangzhou 5
Falls Church 4
New York 4
Zhengzhou 4
Berlin 3
Changchun 3
Los Angeles 3
Washington 3
Borås 2
Costa Mesa 2
Houston 2
Lodi 2
London 2
Ningbo 2
Orange 2
Seattle 2
Taizhou 2
Adelaide 1
Billings 1
Bristol 1
Comazzo 1
Corbetta 1
Fairfield 1
Falkenstein 1
Gunzenhausen 1
Haikou 1
Hamilton 1
Hefei 1
Lanzhou 1
Las Vegas 1
Liverpool 1
Monmouth Junction 1
Piacenza 1
Redwood City 1
Rockville 1
San Francisco 1
San Jose 1
Terrebonne 1
Wetaskiwin 1
Zanjan 1
Totale 2.299
Salva come PNG Salva come JPEG
Nome #
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 84
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 75
Su di uno "strano" epatocarcinoma 75
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 72
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 69
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 65
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 64
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 63
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 63
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 63
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 63
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 63
Clinical significance of hepatitis C virus genotypes. 61
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 61
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 61
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 60
HCV viremia in hemodialysis patients 59
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 58
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 57
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 56
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 55
Association between class II allelles and protection or susceptibility to chronic hepatitis C 55
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 55
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 55
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 54
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 54
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 53
Comparative evaluation of two serologic typing methods of hepatitis C virus 53
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 52
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 52
Hepatitis C virus core serotypes in haemodialysis patients 51
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 51
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 50
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 50
Comparative evaluation of two serological typing methods for hepatitis C virus 50
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 49
HLA genes and chronic hepatitis C severity 49
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 49
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 49
Virological features of HCV infection in hemodialysis patients 48
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 48
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 45
Comparative evaluation of HCV core genotyping and serotyping 45
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 43
Different spectrum of liver disease in patients with HCV genotype II and III infection 41
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 41
Vertical trasnmission of hepatitis C 40
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 39
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 38
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 38
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 38
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 37
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 36
Molecular epidemiology of HCV infection in drug addicts 35
HVR1 variation, viral type and ALT values in chronic HCV infection 35
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 35
Virological feaures of hepatitis C virus infection in hemodialysis patients 34
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 34
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 34
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 33
Significance of hepatitis C virus genotypes 33
null 30
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 27
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 25
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 24
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 23
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 21
Totale 3.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.600
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020918 262 390 0 38 1 39 8 43 1 88 47 1
2020/2021372 38 32 10 37 1 54 1 59 10 65 48 17
2021/2022234 0 1 12 3 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024231 23 55 6 32 27 57 1 23 1 6 0 0
Totale 3.278